Frankfurt
14.07.26 | 15:25
1,570 Euro
0,00 % 0,000
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 03.07. | Diaceutics PLC - PDMR Shareholding/Share Incentive Plan and TVRs | - | RNS | ||
| 25.06. | Diaceutics PLC - Result of AGM | 1 | RNS | ||
| 01.06. | Diaceutics PLC - PDMR Shareholding/Share Incentive Plan & TVRs | - | RNS | ||
| 29.05. | Diaceutics PLC - Notice of AGM & Posting of Annual Report | - | RNS | ||
| 26.05. | Diaceutics says order book and pipeline provides confidence for 2026 | 1 | Alliance News | ||
| DIACEUTICS Aktie jetzt für 0€ handeln | |||||
| 26.05. | Diaceutics PLC - Final Results | - | RNS | ||
| 13.05. | Diaceutics PLC - Notice of Results | - | RNS | ||
| 12.05. | Diaceutics PLC - Holding(s) in Company | - | RNS | ||
| 05.05. | Diaceutics PLC - PDMR Shareholding/Share Incentive Plan and TVRs | - | RNS | ||
| 16.04. | Diaceutics extends Belfast headquarters lease to 2036 | 1 | Investing.com | ||
| 16.04. | Diaceutics PLC - Related Party Transaction - Lease Extension | 1 | RNS | ||
| 01.04. | Diaceutics PLC - PDMR Shareholding/SIP & Total Voting Rights | - | RNS | ||
| 03.03. | Diaceutics PLC - PDMR Shareholding/Share Incentive Plan and TVRs | - | RNS | ||
| 03.02. | Diaceutics PLC - PDMR Shareholding/Share Incentive Plan & TVR | - | RNS |
14 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ATOSSA THERAPEUTICS | 2,040 | +3,55 % | Atossa Therapeutics Inc: Atossa Therapeutics Announces Closing of Registered Direct Offering of up to $16.5 Million in Gross Proceeds | $4.5 million upfront with up to an additional $12 million of potential aggregate gross proceeds upon exercise in full of warrants
SEATTLE, June 12, 2026 /PRNewswire/... ► Artikel lesen | |
| ASENSUS SURGICAL | - | - | Karl Storz to fully integrate Asensus, discontinue Senhance, Luna robots | ||
| SENSEONICS | 4,500 | +1,81 % | Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results | Generated Q4 revenue of $14.3 million, an increase of 72% year-over-year Received CE Mark approval for commercialization of Eversense 365 in Europe Launched first Eversense 365 AID system integration... ► Artikel lesen | |
| VYOME | 2,180 | 0,00 % | Mitschrift des Earnings Call: Vyome Holdings weist für Q1 2026 eine starke Cash-Position aus | ||
| INTELLIGENT BIO SOLUTIONS | 2,250 | 0,00 % | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Initiates Clinical Study Supporting FDA Clearance and Planned U.S. Market Entry | Interference Study designed to validate system specificity in the presence of potentially interfering substances commonly encountered in real-world settings Company expects to complete the study by... ► Artikel lesen | |
| PAVMED | 4,760 | +3,14 % | PAVmed Inc.: PAVmed Provides Business Update and Reports First Quarter 2026 Financial Results | Veris Health progressed commercial expansion and advanced implantable physiological monitor development toward FDA submission
Lucid Diagnostics continued building... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 69,68 | +0,01 % | Raymond James initiates BrightSpring Health stock with outperform rating | ||
| BILLIONTOONE | 124,59 | -0,22 % | BillionToOne, Inc.: BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance | MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 21,210 | +0,05 % | Kaplan Fox & Kilsheimer LLP: Kaplan Fox Alerts Investors of Alignment Healthcare, Inc. (ALHC) to an Investigation of Potential Securities Law Violations | New York, New York--(Newsfile Corp. - July 10, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. ("Alignment Healthcare" or... ► Artikel lesen | |
| BETA BIONICS | 16,860 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Announces First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance | IRVINE, Calif., April 21, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| GENEDX | 62,37 | -0,10 % | Piper Sandler raises GeneDx stock price target on coverage policy | ||
| HEARTFLOW | 25,500 | +0,04 % | Heartflow, Inc.: New Data at SCCT 2026 Reinforce Heartflow Plaque Analysis as the Standard for AI-Powered Coronary Artery Disease Management | ||
| ADAPTHEALTH | 10,190 | 0,00 % | AdaptHealth Flags Material Breach After Threat Actor Accessed Patient Management Systems | ||
| PROCEPT BIOROBOTICS | 19,300 | -0,05 % | PROCEPT BioRobotics to Report Second Quarter 2026 Financial Results on August 4th, 2026 | ||
| PROGYNY | 32,360 | 0,00 % | KeyBanc raises Progyny stock price target on utilization strength |
Das Unternehmen DIACEUTICS PLC kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 1,570 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu DIACEUTICS PLC finden Sie auf Wallstreet Online.